---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-243709"
form_type: "8-K"
ticker: "CTMX"
cik: "0001501989"
company_name: "CytomX Therapeutics, Inc."
filed_at: "2022-09-13T23:59:59+00:00"
generated_at: "2026-06-23T09:59:43.829996+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CytomX enters consulting agreements with former COO and CFO

## Summary
- Amy Peterson, former President and COO, to provide consulting at $500/hour effective Sept 13, 2022.
- Carlos Campoy, SVP and CFO, to provide consulting at $500/hour effective Oct 1, 2022.
- Both agreements have one-year terms with 30-day termination notice.
- Peterson's services include clinical development; Campoy provides biotech and financial advice.

## SEC filing metadata
- accession: 0001193125-22-243709
- form_type: 8-K
- ticker: CTMX
- cik: 0001501989
- company_name: CytomX Therapeutics, Inc.
- filed_at: 2022-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501989/000119312522243709/0001193125-22-243709-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501989/000119312522243709/d335361d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-243709
- JSON: https://secwatch.observer/filing/0001193125-22-243709.json
- Plain text: https://secwatch.observer/filing/0001193125-22-243709.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.